Milestone: Creating Innovative Solutions Milestone Home
 
image thru microscope
Symposia Contact Home

CPSA Digest 2001

New Technologies and Approaches for Increasing Drug Candidate Survivability:
Lead Identification to Lead Optimization

October 9-11, 2001

CPSA Digest 2001

Day 1: Proceedings | Plenary
Day 2: Proceedings
Day 3: Proceedings

CPSA 2001 Sponsors

CPSA Digest Archive
CPSA Digest 2000
CPSA Digest 2001 >>
CPSA Digest 2002
CPSA Digest 2003
CPSA Digest 2004


Proceedings -Wednesday, October 10, 2001

WOA1



Qualitative and Quantitative Mass Spectrometry for Proteomics

David R. Goodlett, The Institute for Systems Biology

Background:
Traditionally, biology has focused on studying individual genes, proteins and organisms in isolation. Systems biology, however, has demonstrated that biologically significant phenomena arise from complex interactions of numerous gene, protein and cell elements that form informational networks and systems. Proteins are vital components of this system and are important for the functioning of cells. Like genes, proteins are critical for controlling biological systems. The capabilities of technology in the future include being able to identify a large percentage of the proteins in both healthy and diseased cells and analyze them all at the same time via advanced mass spectrometry techniques.

Premise:
General research goals of the Institute for Systems Biology are to:

  1. Acquire data for modeling cells; demonstrate the feasibility of creating models for accurately predicting molecular interactions within cells.
  2. Allow the global data to suggest an appropriate hypothesis.
  3. Write algorithms that are predictive. By integrating different types of information, a mathematical model can ultimately be constructed describing the structure and behavior of the cells.

Analysis
As an example of the integration of methods and technologies, huge amounts of data were gathered from genes, proteins and molecular interactions within yeast cells. These data were generated by exposing the pathway of galactose utilization in yeast to a battery of test conditions in which known genes and other molecular components were removed one by one. For each test condition, responses were recorded at several different levels of biological information utilizing state-of-the-art technology:

  • DNA microarrays gathered genomic information revealing which genes were turned on or off under each condition
  • Proteomics techniques measured the types and quantities of the proteins produced by each expressed gene
  • Existing biological databases were mined to identify molecules known to interact in each condition, including data on interactions among proteins as well as between proteins and DNA.

The diverse data types were then integrated using high-throughput computational facilities. The research succeeded in identifying a number of new interactions not previously documented through traditional research methods, opening whole new fields of study.

Protein quantitation and identification techniques can be performed via the unique Isotope Coded Affinity Tag (ICATTM) reagent method. ICAT has been shown to be very promising in its ability to precisely identify, quantify and analyze most of the proteins expressed in a cell or tissue. The figure below represents the range of protein types that can be identified using this technique.


By building on the ICAT technology, a research goal is to take post-genome biology to the next level with high-speed capabilities in proteomics comparable to those that have transformed genomics. Then a true integration of genomics and proteomics will help to understand how biological systems work.

Value of the Technology
The Institute for Systems Biology is formed around the realization that advancing biology in the 21st Century will rely on using advanced biological and computational technologies to generate and correlate many different levels and types of biological information. Unlike traditional scientific approaches that examine single genes or proteins, systems biology focuses on simultaneously studying the complex interaction of vast numbers of biological elements. Ultimately, the modeling approach used promises to revolutionize the study of disease and illness by generating information needed to develop new medical treatments in a much shorter timeframe.

References
Trey Ideker et al., Science, 292, 929-934 (2001).

Links
Institute for Systems Biology


Return to Proceedings »



overview | training | workshops | consulting | symposia | contact | home